▼ PLUNGE

ProPhase Labs Inc.

-32.0%
PRPHNASDAQHealthcare2026-04-16
0.102
Close
0.15
Prev Close
-32.00%
Change
0.9x
Vol Ratio

Why It Plunged

No related news available.

Related News

Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment
Tipranks2026-04-07
Cancer immunotherapy company Purple Biotech keeps its Nasdaq listing
Stocktitan2026-03-17
IPH Ltd. Issues Daily Update on On-Market Share Buy-Back Activity
Tipranks2026-04-12
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
Sa.Marketscreener2026-04-13
Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know
Tipranks2026-04-07

Technical Analysis

No technical analysis available.

View CompanyBack to Surge Stocks
ProPhase Labs Inc. Surged +-32.0% on 2026-04-16 — Analysis | Alpha Lenz